📰 Tuberculosis Research Program News
Tuberculosis Research Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tuberculosis Research Program. Real-time updates on events, politics, business and more.
November 16, 2022
Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.
November 16, 2022
Get latest articles and stories on Health at LatestLY. A novel nasal vaccination method has been created by researchers from the Centenary Institute and the University of Sydney that promotes strong lung immunity and protection against the SARS-CoV-2 coronavirus. Health News | New Nasal Vaccination Approach Might Enhance COVID-19 Protection: Study.
November 4, 2021
Centenary Institute researchers have secured more than $2m in collective funding from the Federal Government in the latest round of National Health
January 20, 2021
Novel Synthesis Method Aids Rapid Testing of Vaccine Strategies against Respiratory Pathogens Source: Robert Hoetink/Fotolia January 20, 2021 Scientists in Australia have developed a method for the rapid synthesis of safe vaccines, and say their approach can be used to create and test potential vaccine strategies against respiratory pathogens, including SARS-CoV-2. Headed by Richard Payne, PhD, at the University of Sydney, and Warwick Britton, PhD, at the Centenary Institute, the research team...
January 19, 2021
New method to assist fast-tracking of vaccines for pre-clinical tests Scientists in Australia have developed a method for the rapid synthesis of safe vaccines, an approach that can be used to test vaccine strategies against novel pandemic pathogens such as SARS-CoV-2, the virus that causes COVID-19. Led by Professor Richard Payne at the University of Sydney and Professor Warwick Britton at the Centenary Institute, the team has demonstrated application of the method with a new vaccine for us...
January 18, 2021
A new method to synthesize vaccines safely and quickly should see much faster pre-clinical testing to pursue strategies to combat novel pathogens, something the COVID pandemic has shown is necessary.